Big Pharma extended bull run 2021

Big Pharma extended bull run 2021

Talking about big business. The vaccine program is booming with sales. Time to get your pie as Big Pharma is quite bullish this 2021. I wonder why?

Not speculative investment. The pharmaceutical industry is made of companies that research, develop, make, and sell drugs and treatments used to treat or eradicate diseases, and vaccinate people.

Johnson & Johnson – JNJ

• 3Y – from 2019 to 2021
• 453 Billion USD market cap
• up from 130 to 173 per share

Sinovac Biotech – SVA

• 1Y – suspended trading at 6.47$
• 460 Million to 3.3 Billion USD
• projected market value if trading resumes

AstraZeneca PLC – AZN

• 3Y – from 2019 to 2021
• 178 Billion USD market cap
• up from 46 to 60.93 per share

Moderna Inc – MRNA

• 3Y – from 2019 to 2021
• 141 Billion USD market cap
• up from 54 to 265 per share

Pfizer Inc – PFE

• 1Y – from 2020 to 2021
• 239 Billion USD market cap
• up from 36 to 44 per share

Gilead Sciences – GILD

• 52 weeks range
• 85 Billion USD market cap
• up from 56 – 72 per share

Disclaimer: This is not financial advice. Invest at your own risk.

#vaccine #BigPharma #BigBusiness #astrazeneca #johnsonandjohnson #coronavac #sinovac #sinopharm #pfizer #moderna #stocks